SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-050938
Filing Date
2018-08-09
Accepted
2018-08-09 16:07:27
Documents
7
Period of Report
2018-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-18382_18k.htm 8-K 25481
2 EX-10.1 a18-18382_1ex10d1.htm EX-10.1 218633
3 EX-99.1 a18-18382_1ex99d1.htm EX-99.1 120834
4 GRAPHIC g183821ko09i001.gif GRAPHIC 76715
5 GRAPHIC g183821ko03i001.gif GRAPHIC 154276
6 GRAPHIC g183821ko03i002.gif GRAPHIC 207949
7 GRAPHIC g183821mmi001.jpg GRAPHIC 2732
  Complete submission text file 0001104659-18-050938.txt   974776
Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 181005072
SIC: 2834 Pharmaceutical Preparations